drugset
drugset / Trial / NCT03289169

Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines

NCT03289169 ↗

Phase 4 Completed 300 enrolled Medy-Tox
NaSingle-groupOpen-labelTreatment

Summary

This study evaluates the long-term safety of repeated administrations of Meditoxin® in the treatment of moderate to severe glabellar lines.

Timeline

Start
2016-12-30
Primary completion
2019-05-29
Completion
2019-05-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Meditoxin Protein / enzyme biologic 20 iu —

Indications

No indication recorded.